0 items USD 0.00Search
Your search for "Hodgkin%20Lymphoma%20" gave back 1650 results.
Bromodomain Containing Protein 2 (Really Interesting New Gene 3 Protein or O27.1.1 or BRD2) Development by Therapy Areas and Indications, Stages, MoA...
Catalog:
Global Markets Direct
March 2022
Price: USD 3,500.00
Bromodomain Containing Protein 2 - Drugs In Development, 2021 Summary According to the recently published report 'Bromodomain Containing Protein...
Catalog:
Global Markets Direct
June 2021
Price: USD 3,500.00
Bendamustine is a chemotherapy medication used in the treatment of chronic lymphocytic leukemia (CLL), multiple myeloma, and non-Hodgkin's...
Catalog:
LPI
January 2023
Price: USD 3,660.00
Aryl Hydrocarbon Receptor - Pipeline Review, H2 2020 Summary Aryl Hydrocarbon Receptor (Class E Basic Helix Loop Helix Protein 76 or bHLHe76 or AHR)...
Catalog:
Global Markets Direct
September 2020
Price: USD 3,500.00
Aryl Hydrocarbon Receptor - Pipeline Review, H1 2020 Summary Aryl Hydrocarbon Receptor (Class E Basic Helix Loop Helix Protein 76 or bHLHe76 or AHR...
Catalog:
Global Markets Direct
March 2020
Price: USD 3,500.00
Bleomycin is an anti-cancer medicine used to treat certain forms of cancer of the head or the neck, cervix (the neck of the womb) and external sexual...
Catalog:
MRRPB5
March 2023
Price: USD 4,900.00
Summary Vinblastinesulphate is a white or light yellow amorphous power, which is easily soluble in water. Vinblastine belongs to the group of cancer-...
Catalog:
HYR
May 2021
Price: USD 2,000.00
Summary Vinblastinesulphate is a white or light yellow amorphous power, which is easily soluble in water. Vinblastine belongs to the group of cancer-...
Catalog:
HYR
January 2021
Price: USD 2,000.00
Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and...
Catalog:
Global Markets Direct
April 2022
Price: USD 3,500.00
C-X-C Chemokine Receptor Type 4 - Pipeline Review, H2 2019 Summary C-X-C Chemokine Receptor Type 4 (FB22 or Fusin or HM89 or LCR1 or Leukocyte...
Catalog:
Global Markets Direct
November 2019
Price: USD 3,500.00
Adcetris is an antibody-drug conjugate medication used to treat relapsed or refractory Hodgkin lymphoma (HL) and systemic anaplastic large cell...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Brentuximab vedotin is an antibody-drug conjugate medication used to treat relapsed or refractory Hodgkin lymphoma (HL) and systemic anaplastic large...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Histone Deacetylase 4 (Histone Deacetylase A or HDAC4 or EC 3.5.1.98) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type...
Catalog:
Global Markets Direct
March 2022
Price: USD 3,500.00
The global Haemato Oncology Testing market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Histone Deacetylase 4 (Histone Deacetylase A or HDAC4 or EC 3.5.1.98) - Drugs in Development, 2021 Summary Histone Deacetylase 4 (Histone Deacetylase...
Catalog:
Global Markets Direct
March 2021
Price: USD 3,500.00
